Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to discuss 2 cheap quality stocks to consider in this heated market.

2 extracted signals · 2 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
10 Oct 2025, 22:21 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to discuss 2 cheap quality stocks to consider in this heated market.
Source overview

AI-generated source summary

The video presents a fundamental analysis of two stocks, Copart (CPRT) and Coca-Cola Femsa (KOF). For CPRT, the analyst indicates the stock is down 20% year-to-date and owns a lot of the junk cars in the United States at auction. The real-estate advantage with a 45% market share. With LiDAR, safety systems, all bells and whistles, one in five cars are totalled after accidents. It's is very expensive to repair. I believes a P/E adjustment to 18 is reasonable. KOF, operating in Latin America, The analyst believes the company has impressive numbers with 4.33% forward and 5.71% FCF (free cash flow) with the capacity of paying back a 4 and a half percent dividend, is well-positioned, also he added a reasonable earning per share could be expected for 2026 with 16.58%

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
2
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
50%
2 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    2 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.3
Tracked signals
327
Historical success
34.1%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail